OpSens is now part of

Opsens – Q3 Results

OPSENS REPORTS Q3 2017 RESULTS  ANOTHER RECORD QUARTER WITH REVENUES UP 130% TO $4.9 MILLION Quebec City, Quebec, June 29, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the third quarter ended May 31, 2017. Highlights […]

Read More…

VISIT OPSENS MEDICAL AT THE 13TH ANNUAL C3 CONFERENCE

Learn more about OptoWire Deux at booth #211 at the 13th Annual Complex Cardiovascular Catheter Therapeutics (C3) Conference, and attend the Opsens sponsored complimentary breakfast educational symposium, “Applying Advanced Physiology Technology in the New PCI Era”. This program is geared […]

Read More…

ROBIN VILLENEUVE APPOINTED AS CHIEF FINANCIAL OFFICER

ROBIN VILLENEUVE APPOINTED AS CHIEF FINANCIAL OFFICER Quebec City, Quebec, June 7, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS)(OTCQX:OPSSF) today announces that to support its growth phase and positioning in the medical market, the Company recruited Robin Villeneuve […]

Read More…